🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
15.76
-0.63 (-3.84%)
At close: Nov 18, 2026, 4:00 PM EST
16.00
+0.24 (1.52%)
Pre-market: Nov 19, 2026, 7:38 AM EST

Arcus Biosciences Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Arcus Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $40.92. The average 1-year stock price forecast is 159.64% higher than the current stock price, while the lowest is $23 (+45.94%) and the highest is $50 (+217.26%).

Price Target: $40.92 (+159.64%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$23$40.92$45$50
Change+45.94%+159.64%+185.53%+217.26%

Analyst Ratings

The average analyst rating for Arcus Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy101010111212
Buy000011
Hold333222
Sell000000
Strong Sell000000
Total131313131515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Hold
Reiterates
$29 → $28
HoldReiterates$29 → $28+77.66%Nov 16, 2026
J.P. Morgan
J.P. Morgan
Buy
Reiterates
$41 → $40
BuyReiterates$41 → $40+153.81%Nov 9, 2026
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$23
HoldReiterates$23+45.94%Nov 6, 2026
Unknown Analyst
Leerink Partners
No rating
Leerink Partners
Buy
Maintains
$46 → $49
BuyMaintains$46 → $49+210.91%Nov 5, 2026
Wedbush
Wedbush
Buy
Reiterates
$49 → $45
BuyReiterates$49 → $45+185.53%Nov 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
72.34M
from 247.00M
Decreased by -70.71%
Revenue Next Year
55.78M
from 72.34M
Decreased by -22.89%
EPS This Year
-3.48
from -3.29
EPS Next Year
-3.09
from -3.48
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
383.00M112.00M117.00M258.00M247.00M72.34M
Revenue Growth
391.03%-70.76%4.46%120.51%-4.26%-70.71%
Operating Income
54.00M-280.00M-340.00M-310.00M-386.00M-478.50M
Net Income
53.00M-267.00M-307.00M-283.00M-353.00M-463.99M
EPS
-----3.29-3.48
Free Cash Flow
-----484.00M-449.00M
No. Analysts
-----13
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High81.5M
Avg72.3M
Low67.0M

Revenue Growth

Revenue Growth202620272028
High
-67.0%
Avg
-70.7%
Low
-72.9%

EPS Forecast

EPS202620272028
High-3.03
Avg-3.48
Low-3.75

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-